Logo

Galileo Genomics Gets $CA7 Million Loan from Investissement Quebec

Jan 19, 2004

NEW YORK, Jan. 19 (GenomeWeb News) - Galileo Genomics has received a loan of $CA7 million ($5.39 million) from Investissement Quebec, the company said today.

 

Galileo, based in Montreal, plans to use the additional funding for its research. Applying its chromozoom technology, the company is trying to find groups of genes associated with more than 20 common diseases by examining DNA samples from the Quebec Founder Population.

 

Earlier this month, Galileo raised $CA11.15 million ($8.58 million) in equity financing.

 

Breaking News
The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.